⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Canara Robeco Flexi Cap Fund - Growth - Direct Plan | Kotak Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Canara Robeco MF | Kotak MF |
| Category | Equity - Flexi Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹382.31 (03 Nov 2026) | ₹17.64 (03 Nov 2026) |
| Rating | ★★★★ | ★★★ |
| Benchmark | BSE 500 - TRI | Nifty Healthcare Index - TRI |
| Fund Manager | Shridatta Bhandwaldar | Dhananjay Tikariha |
| Inception | 01 Jan 2013 | 11 Dec 2023 |
| Returns | ||
| 1Y | -3.26% | 23.77% |
| 3Y | 12.25% | — |
| 5Y | 8.97% | — |
| Since Inception | 13.79% | 21.63% |
| Risk | ||
| 13.36 | 14.88 | |
| 0.96 | 0.99 | |
| 0.37 | 1.02 | |
| 2.51 | 3.82 | |
| 0.66 | 2.12 | |
| -12.02% | -11.03% | |
| Costs | ||
| Expense Ratio | 0.71% | 1.03% |
| Exit Load | 1% on or before 1Y, Nil after 1Y | 0.50% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Canara Robeco…94%
Kotak MF94%
6.3%Only 6.3% of holdings by weight are common between Canara Robeco MF and Kotak MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingCanara Robeco MFKotak MF
Divi's Laboratories Ltd.1.90%9.35%
Torrent Pharmaceuticals Ltd.1.51%4.65%
Max Healthcare Institute Ltd.1.44%3.61%
Sun Pharmaceutical Industries Ltd.1.41%13.21%
Category context: Equity vs Equity. Open the full Screener →